To investigate the evolution of SARS-CoV-2 in the immune population, we co-incubated
authentic virus with a highly neutralizing plasma from a COVID-19 convalescent patient. The …

The emergence of SARS-CoV-2 variants is jeopardizing the effectiveness of current vaccines
and limiting the application of monoclonal antibody-based therapy for COVID-19 (refs. ). …

To investigate the evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
in the immune population, we coincupi bated the authentic virus with a highly …

There are no robust data on the real onset of severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2) infection and spread in the prepandemic period worldwide. We …

A newly identified coronavirus, named SARS-CoV-2, emerged in December 2019 in Hubei
Province, China, and quickly spread throughout the world; so far, it has caused more than …

The recent outbreak of a novel Coronavirus (SARS-CoV-2) and its rapid spread across the
continents has generated an urgent need for assays to detect the neutralising activity of …

The emerging threat represented by SARS-CoV-2 variants, demands the development of
therapies for better clinical management of COVID-19. MAD0004J08 is a potent Fc-engineered …

Nitric oxide (NO) and hydrogen sulfide (H 2 S) are now recognized as gaseous transmitters
with many cardiovascular protective properties. The present study concerns the possibility …

Growing interest in universal influenza vaccines and novel administration routes has led to
the development of alternative serological assays that are able to detect antibodies against …

Background The emerging threat represented by SARS-CoV-2 variants, demands the
development of therapies for better clinical management of COVID-19. MAD0004J08 is an …